NDMA REQUESTS ONE-YEAR EXEMPTION FROM FDA ENFORCEMENT OF PEDICULICIDE
This article was originally published in The Tan Sheet
Executive Summary
NDMA REQUESTS ONE-YEAR EXEMPTION FROM FDA ENFORCEMENT OF PEDICULICIDE monograph labeling requirements at an "OTC feedback" meeting with FDA and the Environmental Protection Agency on April 14. A memo distributed at the meeting by the Nonprescription Drug Manufacturers Association calls for a "transitional period" of "up to one year post the effective date" of the final monograph on pediculicides, which goes into effect on Dec. 14, 1994.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning